Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-014327 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
405,349
Total Value
$940,527.77
P&L
+inf% (+$8,173,280.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 27, 2026 | Grant/Award | 102,000 | $0.00 | $0.00 | 823,306 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 36,281 | $25.16 | $912,851.73 | 787,025 | Direct | โ | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Sale | 1,068 | $25.91 | $27,676.05 | 785,957 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Feb 27, 2026 | Grant/Award | 266,000 | $0.00 | $0.00 | 266,000 | Direct | โ | View Details |